Ammonia Emission, Manure Nutrients and Egg Production of Laying Hens Fed Distiller Dried Grain Diets

A USDA Natural Resources Conservation Service, Conservation Innovation Grant project coordinated by the United Egg Producers (UEP) conducted concurrent demonstrations in Iowa and Pennsylvania (PA) at commercial laying hen facilities. The goal was to document manure nutrient and gas emission improvements through the use of dried distiller’s grain with solubles (DDGS) diets and/or other dietary modifications while maintaining or improving hen productivity. Results of the PA trial are presented here. Diets containing 10% corn DDGS with (D+P) or without (D) the probiotic Provalen™ were compared to a corn-soybean based control diet (CON). The isocaloric, amino acid balanced diets were fed to three groups of 39,800 Lohmann hens in one house. Hens were 20-65 wk of age with each diet provided to 2 of 6 rows of stacked cages with manure belts (six decks high). Feed intake, water consumption, hen body weight (BW), egg production (EP,) egg case weight, mortality, feed cost (FC), and egg income (EI) were provided weekly by the cooperating egg company. Replicated monthly data, including egg weight (EW), albumen height (AH), Haugh units (HU), yolk color (YC), shell strength (SS) and shell thickness (ST), were determined from eggs collected from six 4-cage sections of hens on each diet. Replicated monthly samples of hen manure (fresh and from storage) were analyzed for moisture and major nutrients. Ammonia (NH3) gas measurements utilized a non-steady state flux chamber method coupled with photoacoustic infrared gas analyzer. There was no clear trend in the magnitude of NH3 emissions relative to the diets within the hen house as measured on the manure belt. At 32 and 36 wks of age, NH3 emissions were significantly (P \u3c 0.10) higher in D while D+P and CON were lower and similar. At 48 and 52 wks, NH3 emissions from D were similar to D+P and significantly lower than CON. Emission rate from belt manure averaged 0.42 ±0.025 g bird-1 d-1 for all treatments and dates. There was no significant impact of diet on BW, EW, HU, SS, or ST (P =0.10 to 0.66), however, CON hens had lower EP, AH, and YC compared to D and D+P hens (P=0.05). Fresh manure total phosphorus (P2O5) was higher for CON samples (P \u3c 0.05) while other major agronomic nutrients and moisture were not significantly different among treatments. Stored CON manure samples had increased moisture and NH4-N compared to those of D and D+P treatments (P \u3c 0.10). Weekly EI minus FC averaged $6,146,$6,215, and $6,209 for the CON, D, and D+P diets, respectively

Evaluation of odor emissions from amended dairy manure: preliminary screening

Manure amendments have shown variable effectiveness in reducing odor.  Twenty-two amendments were applied to dairy manure then evaluated for odor reduction efficacy after storage at 20℃ for 3 d and 30 d.  Amendments represented differing primary modes of action including: microbial digestive, oxidizing, disinfecting, masking, and adsorbent.  Each amendment was added to 2 kg dairy manure (1:1.7 urine:feces; 12% total solids) following recommended rates.  In this preliminary screening, one sample (n=1) of each amendment was evaluated along with untreated manure (Control).  Odor emission from each treated manure and Control was estimated twice by five or six qualified odor assessors (n=10 or 12) after each storage duration, using an international standard for triangular forced-choice olfactometry.  Odor quality was defined using hedonic tone, Labeled Magnitude Scale and ASTM methods for supra-threshold odor intensity, and an odor character wheel for descriptors.  For selected treatments, odor emissions were significantly reduced relative to Control at 30 d versus 3 d incubation (P<0.0001).  However, no amendment was significantly effective for both incubation times.  Likewise, for all amendments tested, aging the manure slurry for 30 d significantly reduced odor emission and odor intensity (P<0.0001).  A proprietary microbial amendment (Alken Enz-Odor + Clear Flo: aerobic/ facultative microbes with growth factors), disinfectant (hydrogen peroxide), and masking agent (Hyssopus officinalis essential oil) provided significant short-term control of odor (P <0.06).  However, after 30 d seven amendments significantly increased odor emission (P<0.02) while only two amendments offered a significant efficacy (P<0.0001): a proprietary microbial aerobic/facultative product (Bio-Regen) and a proprietary mix of chemicals (Greaseater), both with weekly re-application.  Hedonic tone observations suggested an improvement to “slightly to moderately unpleasant” smell versus untreated manure for all amendments except clinoptilolite zeolite adsorbent.  Hedonic tone improvement was correlated with reduced manure odor supra-threshold intensity.Keywords: odor, hedonic tone, odor strength, amendments, additives, dairy manure, United States of Americ

Manure amendments for mitigation of dairy ammonia and greenhouse gas emissions: preliminary screening

 Amendments can be practical and cost-effective for reducing ammonia [NH3] and greenhouse gas [GHG] emissions from dairy manure.  In this study, the effect of 22 amendments on NH3 and GHG carbon dioxide [CO2], methane [CH4] and nitrous oxide [N2O] emissions from dairy manure were simultaneous investigated at room temperature (20℃).  Dairy manure slurry (2 kg; 1:1.7 urine: feces; 12% total solids) was treated with various amendments, representing different classes of product, following the suppliers’ recommended rates.  In this screening of products, one sample of each amendment was evaluated along with untreated manure slurry with repeated measurements over 24 h.  Gas emissions were measured after short (3 d) and medium (30 d) storage duration using a photoacoustic multi-gas analyzer.  Six amendment products that acted as microbial digest, oxidizing agent, masking agent or adsorbent significantly reduced NH3 by >10% (P = 0.04 to <0.001) after both 3 and 30 d.  Microbial digest/enzymes with nitrogen substrate appeared effective in reducing CH4 fluxes for both storage times.  Most of the masking agents and disinfectants significantly increased CH4 in both storage periods (P = 0.04 to <0.001).  For both CH4 and CO2 fluxes, aging the manure slurry for 30 d significantly reduced gas production by 11 to 100% (P<0.001).  While some products reduced emissions at one or both storage times, results showed that the ability of amendments to mitigate emissions from dairy manure is finite and re-application may be required even for a static amount of manure.  Simultaneous measurement of gases identified glycerol as a successful NH3 reduction agent while increasing CH4 in contrast to a digestive-microbial product that significantly reduced CH4 while enhancing NH3 release.Keywords: methane, greenhouse gas, emission, amendment, additive, dairy manure, ammonia, mitigatio

Lack of Evidence for Neonatal Misoprostol Neurodevelopmental Toxicity in C57BL6/J Mice

Misoprostol is a synthetic analogue of prostaglandin E1 that is administered to women at high doses to induce uterine contractions for early pregnancy termination and at low doses to aid in cervical priming during labor. Because of the known teratogenic effects of misoprostol when given during gestation and its effects on axonal growth in vitro, we examined misoprostol for its potential as a neurodevelopmental toxicant when administered to neonatal C57BL6/J mice. Mice were injected subcutaneously (s.c.) with 0.4, 4 or 40 µg/kg misoprostol on postnatal day 7, the approximate developmental stage in mice of human birth, after which neonatal somatic growth, and sensory and motor system development were assessed. These doses were selected to span the range of human exposure used to induce labor. In addition, adult mice underwent a battery of behavioral tests relevant to neurodevelopmental disorders such as autism including tests for anxiety, stereotyped behaviors, social communication and interactions, and learning and memory. No significant effects of exposure were found for any measure of development or behavioral endpoints. In conclusion, the results of the present study in C57BL/6J mice do not provide support for neurodevelopmental toxicity after misoprostol administration approximating human doses and timed to coincide with the developmental stage of human birth

CyanoFactory, a European consortium to develop technologies needed to advance cyanobacteria as chassis for production of chemicals and fuels

CyanoFactory, Design, construction and demonstration of solar biofuel production using novel (photo)synthetic cell factories, was an R&D project developed in response to the European Commission FP7-ENERGY-2012-1 call “Future Emerging Technologies” and the need for significant advances in both new science and technologies to convert solar energy into a fuel. CyanoFactory was an example of “purpose driven” research and development with identified scientific goals and creation of new technologies. The present overview highlights significant outcomes of the project, three years after its successful completion. The scientific progress of CyanoFactory involved: (i) development of a ToolBox for cyanobacterial synthetic biology; (ii) construction of DataWarehouse/Bioinformatics web-based capacities and functions; (iii) improvement of chassis growth, functionality and robustness; (iv) introduction of custom designed genetic constructs into cyanobacteria, (v) improvement of photosynthetic efficiency towards hydrogen production; (vi) biosafety mechanisms; (vii) analyses of the designed cyanobacterial cells to identify bottlenecks with suggestions on further improvements; (viii) metabolic modelling of engineered cells; (ix) development of an efficient laboratory scale photobioreactor unit; and (x) the assembly and experimental performance assessment of a larger (1350 L) outdoor flat panel photobioreactor system during two seasons. CyanoFactory - Custom design and purpose construction of microbial cells for the production of desired products using synthetic biology – aimed to go beyond conventional paths to pursue innovative and high impact goals. CyanoFactory brought together ten leading European partners (universities, research organizations and enterprises) with a common goal – to develop the future technologies in Synthetic biology and Advanced photobioreactors

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

BACKGROUND : In many countries, regular monitoring of the emergence of resistance to anti-tuberculosis drugs is hampered by the limitations of phenotypic testing for drug susceptibility. We therefore evaluated the use of genetic sequencing for surveillance of drug resistance in tuberculosis. METHODS : Population-level surveys were done in hospitals and clinics in seven countries (Azerbaijan, Bangladesh, Belarus, Pakistan, Philippines, South Africa, and Ukraine) to evaluate the use of genetic sequencing to estimate the resistance of Mycobacterium tuberculosis isolates to rifampicin, isoniazid, ofloxacin, moxifloxacin, pyrazinamide, kanamycin, amikacin, and capreomycin. For each drug, we assessed the accuracy of genetic sequencing by a comparison of the adjusted prevalence of resistance, measured by genetic sequencing, with the true prevalence of resistance, determined by phenotypic testing. FINDINGS : Isolates were taken from 7094 patients with tuberculosis who were enrolled in the study between November, 2009, and May, 2014. In all tuberculosis cases, the overall pooled sensitivity values for predicting resistance by genetic sequencing were 91% (95% CI 87–94) for rpoB (rifampicin resistance), 86% (74–93) for katG, inhA, and fabG promoter combined (isoniazid resistance), 54% (39–68) for pncA (pyrazinamide resistance), 85% (77–91) for gyrA and gyrB combined (ofloxacin resistance), and 88% (81–92) for gyrA and gyrB combined (moxifloxacin resistance). For nearly all drugs and in most settings, there was a large overlap in the estimated prevalence of drug resistance by genetic sequencing and the estimated prevalence by phenotypic testing. INTERPRETATION : Genetic sequencing can be a valuable tool for surveillance of drug resistance, providing new opportunities to monitor drug resistance in tuberculosis in resource-poor countries. Before its widespread adoption for surveillance purposes, there is a need to standardise DNA extraction methods, recording and reporting nomenclature, and data interpretation.The Bill & Melinda Gates Foundation, the United States Agency for International Development, and the TB Alliance.www.thelancet.com/infectionhttp://www.thelancet.com/infectionam2018Medical Microbiolog